Is there a place for radiotherapy in low-grade gliomas? (Q33526614)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20102114 AND SRC:MED&resulttype=core&format=json

17 January 2020

review article

1 reference

title

Is there a place for radiotherapy in low-grade gliomas? (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20102114 AND SRC:MED&resulttype=core&format=json

adaptive radiation therapy

17 January 2020

main subject

0 references

author name string

B G Baumert

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20102114 AND SRC:MED&resulttype=core&format=json

17 January 2020

R Stupp

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20102114 AND SRC:MED&resulttype=core&format=json

17 January 2020

publication date

1 January 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20102114 AND SRC:MED&resulttype=core&format=json

Advances and Technical Standards in Neurosurgery

17 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20102114 AND SRC:MED&resulttype=core&format=json

17 January 2020

volume

35

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20102114 AND SRC:MED&resulttype=core&format=json

17 January 2020

page(s)

159-182

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20102114 AND SRC:MED&resulttype=core&format=json

Pretreatment factors predict overall survival for patients with low-grade glioma: a recursive partitioning analysis

17 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

Phase II study of primary temozolomide chemotherapy in patients with WHO grade II gliomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

Effects of radiotherapy on cognitive function in patients with low-grade glioma measured by the folstein mini-mental state examination

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

Importance of baseline mini-mental state examination as a prognostic factor for patients with low-grade glioma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

The neurocognitive effects of radiation in adult low-grade glioma patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

Phase II evaluation of recombinant interferon alpha and BCNU in recurrent glioma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

Phase II trial of procarbazine, lomustine, and vincristine as initial therapy for patients with low-grade oligodendroglioma or oligoastrocytoma: efficacy and associations with chromosomal abnormalities

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

Oligodendrogliomas. I. A clinical study of cerebral oligodendrogliomas.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

Efficacy of fractionated stereotactic reirradiation in recurrent gliomas: long-term results in 172 patients treated in a single institution.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

Cognitive functions in low-grade gliomas: disease and treatment effects.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

Longitudinal cognitive follow-up in low grade gliomas.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

The dose-volume interaction in adult supratentorial low-grade glioma: higher radiation dose is beneficial among patients with partial resection.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

Ki-67: a prognostic factor for low-grade glioma?

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

Dose-escalation with proton/photon irradiation for Daumas-Duport lower-grade glioma: results of an institutional phase I/II trial.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

Phase II trial of nitrogen mustard, vincristine, and procarbazine in patients with recurrent glioma: North Central Cancer Treatment Group results

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

Neuropsychometric evaluation of long-term survivors of adult brain tumours: relationship with tumour and treatment parameters

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

Whole brain radiotherapy with hippocampal avoidance and simultaneously integrated brain metastases boost: a planning study

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

Gamma knife surgery for low-grade gliomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

Treatment of low-grade oligodendroglial tumors without radiotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

Temozolomide as initial treatment for adults with low-grade oligodendrogliomas or oligoastrocytomas and correlation with chromosome 1p deletions

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

A t(1;19)(q10;p10) mediates the combined deletions of 1p and 19q and predicts a better prognosis of patients with oligodendroglioma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

Randomized trial on the efficacy of radiotherapy for cerebral low-grade glioma in the adult: European Organization for Research and Treatment of Cancer Study 22845 with the Medical Research Council study BRO4: an interim analysis

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

A randomized trial on dose-response in radiation therapy of low-grade cerebral glioma: European Organization for Research and Treatment of Cancer (EORTC) Study 22844.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

A phase II study of extended low-dose temozolomide in recurrent malignant gliomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

Quality of life after radiation therapy of cerebral low-grade gliomas of the adult: results of a randomised phase III trial on dose response (EORTC trial 22844). EORTC Radiotherapy Co-operative Group.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

Effect of radiotherapy and other treatment-related factors on mid-term to long-term cognitive sequelae in low-grade gliomas: a comparative study

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

Immediate postoperative radiotherapy or "watch and wait" in the management of adult low-grade glioma?

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

Neurosurgical management of low-grade astrocytoma of the cerebral hemispheres

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

The role of radiation therapy in the treatment of astrocytomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

Progressive low-grade oligodendrogliomas: response to temozolomide and correlation between genetic profile and O6-methylguanine DNA methyltransferase protein expression

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

Statistical analysis of clinicopathological features, radiotherapy, and survival in 170 cases of oligodendroglioma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

Survival, prognostic factors, and therapeutic efficacy in low-grade glioma: a retrospective study in 379 patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

Cognitive function after radiotherapy for supratentorial low-grade glioma: a North Central Cancer Treatment Group prospective study.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

Low-grade oligodendroglioma responds to chemotherapy.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

Low-grade astrocytomas: treatment results and prognostic variables

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

Radiotherapy for supratentorial low-grade gliomas: results and prognostic factors with special focus on tumour volume parameters

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

Radiotherapy in low-grade gliomas: Cons

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

Low-grade cerebral astrocytomas. Survival and quality of life after radiation therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

Long-term outcome of low-grade oligodendroglioma and mixed glioma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

Temozolomide chemotherapy for progressive low-grade glioma: clinical benefits and radiological response

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

Prognostic significance of Ki-67 labeling indices obtained using MIB-1 monoclonal antibody in patients with supratentorial astrocytomas.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

Prognostic factors for survival in adult patients with cerebral low-grade glioma.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

Fractionated stereotactic radiotherapy in low-grade astrocytomas: Long-term outcome and prognostic factors

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

Toxicity and efficacy of protracted low dose temozolomide for the treatment of low grade gliomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

Phase II trial of temozolomide in patients with progressive low-grade glioma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

Stereotactic radiosurgery in the management of intracranial gliomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

A long term study of patients with oligodendrogliomas. Follow-up of 50 cases, including Dr. Harvey Cushing's series

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

Temozolomide and radiation in low-grade and anaplastic gliomas: temoradiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

Radiation therapy in the management of low-grade supratentorial astrocytomas.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

Postoperative radiotherapy of supratentorial low-grade gliomas.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

Prospective randomized trial of low- versus high-dose radiation therapy in adults with supratentorial low-grade glioma: initial report of a North Central Cancer Treatment Group/Radiation Therapy Oncology Group/Eastern Cooperative Oncology Group stud

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

Recurrence following neurosurgeon-determined gross-total resection of adult supratentorial low-grade glioma: results of a prospective clinical trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

THERAPEUTIC CONSIDERATIONS IN TUMORS AFFECTING THE CENTRAL NERVOUS SYSTEM: OLIGODENDROGLIOMAS.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

Supratentorial low-grade astrocytoma. Correlation of computed tomography findings with effect of radiation therapy and prognostic variables

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

Management of oligodendrogliomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

PCV chemotherapy for recurrent oligodendrogliomas and oligoastrocytomas.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

Adverse long-term effects of brain radiotherapy in adult low-grade glioma patients

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

Prognostic factors for low-grade gliomas.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

Cognitive functions and quality of life in patients with low-grade gliomas: the impact of radiotherapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

Three-dimensional treatment planning of astrocytomas: a dosimetric study of cerebral irradiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

Marked inactivation of O6-alkylguanine-DNA alkyltransferase activity with protracted temozolomide schedules

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

Temozolomide three weeks on and one week off as first line therapy for patients with recurrent or progressive low grade gliomas

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

Long-term efficacy of early versus delayed radiotherapy for low-grade astrocytoma and oligodendroglioma in adults: the EORTC 22845 randomised trial

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

Temozolomide chemotherapy in recurrent oligodendroglioma

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

Response rate and prognostic factors of recurrent oligodendroglioma treated with procarbazine, CCNU, and vincristine chemotherapy. Dutch Neuro-oncology Group.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

Phase II study of first-line chemotherapy with temozolomide in recurrent oligodendroglial tumors: the European Organization for Research and Treatment of Cancer Brain Tumor Group Study 26971.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

Low-grade astrocytoma: treatment with conventionally fractionated stereotactic radiation therapy

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

A prospective study of cognitive functions following conventional radiotherapy for supratentorial gliomas in young adults: 4-year results.

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

Treatment of oligodendrogliomas with or without postoperative irradiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

Low grade glioma of the cerebral hemispheres in adults: a retrospective analysis of 88 cases

31 March 2020

1 reference

https://api.crossref.org/works/10.1007/978-3-211-99481-8_6

10.1007/978-3-211-99481-8_6

31 March 2020

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20102114 AND SRC:MED&resulttype=core&format=json

17 January 2020

1 reference